Citigroup Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $140

Zimmer Biomet Holdings, Inc. -1.56%

Zimmer Biomet Holdings, Inc.

ZBH

122.07

-1.56%

Citigroup analyst Joanne Wuensch maintains Zimmer Biomet Holdings (NYSE: ZBH) with a Neutral and raises the price target from $134 to $140.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via